🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

COVID-19 fatality rate down 30% since April, study finds

Published 2020-11-12, 05:22 p/m
© Reuters. FILE PHOTO: A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus linked to COVID-19

By Deena Beasley

(Reuters) - The likelihood that a coronavirus infection will prove fatal has dropped by nearly a third since April due to improved treatment, researchers at the University of Washington’s Institute for Health Metrics and Evaluation (IHME) said on Thursday.

In the United States, COVID-19 now kills about 0.6% of people infected with the virus, compared with around 0.9% early in the pandemic, IHME Director Dr. Christopher Murray told Reuters.

He said statistics reflect that doctors have figured out better ways to care for patients, including the use of blood thinners and oxygen support. Effective treatments, such as the generic steroid dexamethasone, have also been identified.

Experts have struggled to accurately measure a crucial metric in the pandemic: the fatality rate, or percentage of people infected with the pathogen who are likely to die. The difficulty is exacerbated by the fact that many people who become infected do not experience symptoms and are never identified.

IHME said it had been using an infection-fatality rate (IFR) derived from surveys after accounting for age. Older people are at much higher risk of dying from COVID-19 than younger people.

"We know the risk is profoundly age-related. For every one year of age, the risk of death increases by 9%," Murray said.

The Seattle institute, an influential source of COVID-19 forecasts, said it has also determined that the fatality rate for COVID-19 is worse in communities with high levels of obesity.

The group said it has now switched to an IFR that varies over time - declining since the first pandemic wave in March and April by around 0.19% per day until the beginning of September.

It also varies across locations as a function of obesity prevalence, and continues to vary based on population distribution by age.

IHME said its analysis of age-standardized fatality rates from more than 300 surveys suggests a 30% decline since March/April.

Despite that positive trend, infections and hospitalizations have spiked across the country in recent weeks. The group said its modeling suggests 439,000 cumulative U.S. deaths by March 1, and a peak of daily deaths in mid-January at 2,200.

© Reuters. FILE PHOTO: A computer image created by Nexu Science Communication together with Trinity College in Dublin, shows a model structurally representative of a betacoronavirus which is the type of virus linked to COVID-19

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.